The UK’s Horizon trial will test a vaccine against the Epstein-Barr virus (EBV), linked to multiple sclerosis, aiming to train the immune system and explore a potential new treatment for MS.
In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.
Jacqueline Alvarez, Chief of the Chemicals and Health Branch at the UN Environment Programme (UNEP), explores the importance of holistic, One Health efforts to mitigate the growing threat of antimicrobial resistance.
Most medication errors are preventable with the right conditions. Successful technology implementation requires careful planning, proper training, and a commitment to system-wide improvements, as explained by Stéphane Boulanger, Policy Advisor at the European Patient Safety Foundation (EUPSF).
A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.
A landmark study presented at ESCMID Global 2025 reveals the devastating impact of antimicrobial resistance (AMR) on children's health. In 2022, over 3 million children worldwide died from antibiotic-resistant infections, highlighting the urgent need for global action.
New research in the Canadian Medical Association Journal links emergency department opioid prescriptions to small increases in future opioid use and hospitalisations, but not death or overdose. The study highlights the need for cautious prescribing, especially in high-risk patients.
